First pharmaceutical application of XMReality Remote Guidance
XMReality AB announces that Alfasigma s.p.A, an Italian pharmaceutical company, will start to deploy XMReality Remote Guidance in their operations. The initial contract includes mainly software and is of recurring character.
This is the first pharmaceutical application of XMReality Remote Guidance and Alfasigma are planning to deploy Remote Guidance in several steps of their operations, including remote customer visits, inspections and audits, technical assistance from suppliers and also as support between their factories. Alfasigma have several production sites in Italy and a large number of subsidiaries spread around the world.
‘’Previously we have applications in the telemedicine sector. However, to now see XMReality Remote Guidance finding its way into the pharmaceutical sector through Alfasigma is a milestone for us. We will do our utmost to support Alfasigma going forward”, says Jörgen Remmelg, CEO at XMReality.
XMReality AB (publ) develops and sells solutions that revolutionize knowledge sharing through augmented reality (AR). The company is a market leader in remote guidance, which uses AR to guide onsite staff so that they can resolve or prevent problems. XMReality’s customers are mainly global industrial companies, including Bosch Rexroth, Siemens Industrial Turbomachinery, Electrolux, and Bombardier. XMReality is headquartered in Linköping, Sweden, and is listed on Nasdaq First North (ticker: XMR). www.xmreality.com